Prognostic significance of CD83 positive tumor-infiltrating dendritic cells and expression of TGF-beta 1 in human gastric cancer

Hepato-Gastroenterology

Volumn 58, Issue 110-111, 2011, Pages 1834-1840

  Ananiev, Julian ^a   Gulubova, Maya Vladova ^a   Manolova, Irena ^b  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b University Hospital   (Bulgaria)

Author keywords

CD1a; CD83; Dendritic cell; Gastric cancer; Immunohistochemistry; Prognosis; TGF 1

Indexed keywords

CD83 ANTIGEN; T6 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DENDRITIC CELL; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR INFILTRATING DENDRITIC CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD1; CHI-SQUARE DISTRIBUTION; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA;

EID: 83355169829     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Hohenberger P, Gretschel S: Ggastric cancer. Llancet 2003; 362:305-315.
2. Iwamoto M, Shinohara H, Miyamoto A, Okuzawa M, et al.: Prognostic value of tumor in filtrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 2003; 104(1):92-97. (Pubitemid 36184151)
3. Sandel MH, Dadabayev AR, Menon AG, et al.: Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res 2005; 11(7):2576-82. (Pubitemid 40569456)
4. Faith A, Peek E, Donald JM, et al.: Plasmacytoid dendritic cells from human lung cancer draining lymph nodes induce Tc1 responses. American Journal of Respiratory Cell and Molecular Biology 2007; 36(3):360-367. (Pubitemid 46365287)
5. Huang JA, Huang HD, Peng QB, et al.: S100 protein-positive dendritic cells and the significance of their density in gastric precancerous lesions. Proc Chin Acad Med Sci Peking Union Med Coll 1990; 5:93-6.
6. Becker Y: Anticancer role of dendritic cells (DC) in human and experimental cancers - a review. Anticancer Res 1992;12:511-20.
7. Tsujitani S, Kakeji Y, Watanabe A, et al.: Infiltration of S-100 protein positive dendritic cells and peritoneal recurrence in advanced gastric cancer. Int Surg 1992; 77:238-41.
8. Ishigami S, Aikou T, Natsugoe S, et al.: Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology 1998; 55:65-9. (Pubitemid 128707626)
9. Maehara Y, Kabashima A, Tokunaga E, et al.: Recurrences and relation to tumor growth potential and local immune response in node-negative advanced gastric cancer. Oncology 1999; 56:322-7. (Pubitemid 29240358)
10. Ishigami S, Natsugoe S, Uenosono Y, et al.: Infiltration of antitumor immunocytes into the sentinel node in gastric cancer. J Gastrointest Surg 2003; 7:735-739. (Pubitemid 37103126)
11. Ishigami S, Natsugoe S, Tokuda K, et al.: Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett 2000; 159: 103-108.
12. Vicari AP, Caux C, Trinchieri G: Tumour escape from immune surveillance through dendritic cell inactivation. Semin Cancer Biol. 2002 Feb;12(1):33-42. (Pubitemid 34087896)
13. Letterio JJ, Roberts AB: Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998, 16:137-161.
14. Fujiwara T, Stolker JM, Watanabe T, et al.: Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 1998; 153:1063-1078. (Pubitemid 28465830)
15. Markowitz SD, Roberts AB: Tumor suppressor activity of the TGF 6 pathway in human cancers. Cytokine Growth Factor Rev 1996; 7:93-102. (Pubitemid 27202668)
16. Shurin MR, Shurin GV, Lokshin A, et al.: Intratumoral cytokines /chemokines/ growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis Rev 2006; 25:333-356. (Pubitemid 44922354)
17. Ebert MP, Yu J, Miehlke S, et al.: Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer. Br J Cancer. 2000; 82(11):1795-800. (Pubitemid 30307391)
18. Polyak K: Negative regulation of cell growth by TGF beta. Bichem Biophys Acta 1996; 1242:185-199.
19. Hsu S, Huang F, Hafez M, Winawer S, Friedman E: Colon carcinoma cells switch their response to transforming growth factor β with tumor progression. Cell Growth Differ 1994; 5: 267-275. (Pubitemid 24251376)
20. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
21. Sobin LH, Wittekind CH (eds): Wiley-Liss UICC. TNM Classification of Malignant Tumours 6th ed: New York 2002.
22. Kioshima T, Kobayashi I, Matsuo K: Immunohistochemical localization of laminin, collagen type IV and heparan sulfate proteoglycan in human colorectal adenocarcinoma: correlation with local invasive pattern and lymph node metastasis. Acta Histochem Cytochem 1998; 31:39-47. (Pubitemid 28228868)
23. Gulubova M: S-100 protein-positive structures in the liver of patients with liver metastases from colorectal cancer. Savr Med 2004; 55(6):21-26.
24. Inoue M, Tsugane S: Epidemiology of gastric cancer in Japan. Postgrad Med J 2005; 81:419-424. (Pubitemid 41002579)
25. Massagué J: TGFbeta in Cancer. Cell 2008; 134(2):215-30.
26. Ishigami S, Aikou T, Natsugoe S, et al.: Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology 1998; 55(1):65-69. (Pubitemid 128707626)
27. Suzuki A, Masuda A, Nagata H, et al.: Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. J Pathol 2002; 196(1):37-43.
28. Gulubova M, Manolova I, Cirovski G, et al.: Recruitment of dendritic cells in human liver with metastases. Clin Exp Metastasis 2008; 25:777-785.
29. Becker Y: Anticancer role of dendritic cells (DC) in human and experimental cancers-a review. Anticancer Res 1992; 12:511-20.
30. Bell D, Chomarat P, Broyles D, et al.: In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999; 190:1417-26.
31. Salaun B, de Saint-Vis B, Clair-Moninot V, et al.: Cloning and characterization of the mouse homologue of the human dendritic cell maturation marker CD208/DC-LAMP. Eur J Immunol 2003; 33(9):2619-29. (Pubitemid 37138993)
32. Ishigami S, Ueno S, Matsumoto M, et al.: Prognostic value of CD208-positive cell infiltration in gastric cancer. Cancer Immunol Immunother 2010; 59(3):389-95.
33. Kakeji Y, Maehara Y, Korenaga D, et al.: Prognostic significance of tumor-host interaction in clinical gastric cancer: relationship between DNA ploidy and dendritic cell infiltration. J Surg Oncol 1993; 52(4):207-12. (Pubitemid 23121933)
34. Tsukayama S, Omura K, Yoshida K, et al.: Prognostic value of CD83-positive mature dendritic cells and their relation to vascular endothelial growth factor in advanced human gastric cancer. Oncol Rep 2005; 14(2):369-75.
35. Fischer JR, Darjes H, Lahm H, et al.: Constitutive secretion of bioactive transforming growth factor β1 by small cell lung cancer cell lines. Eur J Cancer 1994; 30A:2125-2129.
36. Park YE, Choi YH, Lee WY, et al.: Transforming growth factor beta 1 expression in gastric carcinoma. J Korean Med Sci 1997; 12(3):215-20.
37. Park D 2nd, Son HJ, Song SY, et al.: Role of TGF-beta 1 and TGF-beta type II receptor in gastric cancer. Korean J Intern Med. 2002; 17(3): 160-6.
38. Macarthur M, Hold GL, El-Omar EM: Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 2004; 286(4):G515-20. (Pubitemid 38374969)
39. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998; 392:245-52. (Pubitemid 28155090)
40. Lu L, Li W, Fu F, et al.: Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 1997; 64:1808-15.
41. Buelens C, Willems F, Delvaux A, et al.: Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 1995; 25:2668-72.
42. Saito H, Tsujitani S, Oka S, et al.: An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma. Anticancer Res. 2000; 20(6B):4489-93. (Pubitemid 32141808)
43. Hawinkels LJ, Verspaget HW, van Duijn W, et al.: Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients. Br J Cancer 2007; 97(3):398-404. (Pubitemid 47196749)
44. Guzinska-Ustymowicz K, Kemona A: Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer. World J Gastroenterol 2005; 11(8):1193-5. (Pubitemid 40353008)
45. Nakamura M, Katano M, Kuwahara A, et al.: Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinoma. Br J Cancer 1998; 78(10):1373-8. (Pubitemid 28495253)